Articles
Measuring productive innovation (part III)

Measuring productive innovation (part III)

In the final part of our three part video interview, Mike Rea explains what drives innovation in pharma and how the Productive Innovation Index can be used. In part III of this three part interview, we explored where innovation sits in a company, how the index can be used and what inspiration can be drawn from outside pharma…

Articles
Is it time for pharma to build a dialogue with patients? (part I)

Is it time for pharma to build a dialogue with patients? (pa...

With pharma facing increasing challenges, Mat Phillips questions whether it’s time for them to start reaching out to patients in order to regain some trust. The pharmaceutical industry, perhaps for the first time, is facing an almost ‘perfect storm’ of challenges, and having to…

Articles
Maintaining momentum through mergers and acquisitions

Maintaining momentum through mergers and acquisitions

Shareholders like the prospect of a big merger or acquisition, but pharmaphorum hears how keeping employees and customers on board are the real keys to success. As pharma looks for further innovation and diversification to maintain growth, the appetite for acquisitions and mergers seems to continue unabated…

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more